Drugs.com
SEPTEMBER 22, 2024
SUNDAY, Sept. 22, 2024 -- It's that time of year when respiratory viruses start to circulate widely, but how can you tell the difference between the symptoms of a cold, the flu and COVID?Dr. William Brian Glenn, from Hackensack Meridian Medical.
Covalent Modifiers
SEPTEMBER 22, 2024
Andrew D Huber, Taosheng Chen eLife 2024, 13 :e101446. [link] The article presents the discussion on interaction of covalent inhibitors GW9662 and T0070907 with the peroxisome proliferator-activated receptor gamma (PPARγ), revealing new insights into how these compounds influence receptor activity. Topics include the role of PPARγ in regulating fatty tissue and glucose levels; and the effects of covalent inhibitors on PPARγ's ligand-binding site and its interaction with co-activators and co-repr
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Perficient: Drug Development
SEPTEMBER 22, 2024
In Part 1 of this series, we explored the basics of state management in Lightning Web Components (LWC), focusing on local state management within individual components. If you haven’t read it yet, I recommend starting with Part 1 to grasp the foundational concepts. In this second part, we’ll dive into more advanced territory: shared and global state management.
FDA Law Blog: Biosimilars
SEPTEMBER 22, 2024
By Steven J. Gonzalez & Lisa M. Baumhardt, Senior Medical Device Regulation Expert — On August 22, 2024, FDA hosted a webinar to provide further guidance on the regulatory requirements it intends to apply to Laboratory Developed Test (LDT) developers in Stage 1 of the phaseout policy of the LDT Final Rule – during which FDA has said laboratories developing LDTs will need to comply with Medical Device Reporting (MDR) (21 CFR Part 803), Corrections and Removals (21 CFR Part 806), and Complaint
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Perficient: Drug Development
SEPTEMBER 22, 2024
In an increasingly digital world, security is a top priority for organizations handling sensitive data, especially on platforms like Salesforce. As cyber threats become more sophisticated, traditional security measures may no longer be enough to protect against emerging risks. Enter Artificial Intelligence (AI), which offers a game-changing approach to Salesforce security by detecting anomalies, identifying potential threats, and automating responses.
Codon
SEPTEMBER 22, 2024
Today, we’re launching Issue 04 with this essay about the future of fertility and in vitro oogenesis — a technology that could soon be used to convert human skin cells into eggs or sperm — by one of its foremost developers. Thanks for reading. In March 2023, a research team at Osaka University announced an extraordinary achievement : the production of viable eggs using cells taken from male mice.
Expert insights. Personalized for you.
98 
Let's personalize your content